Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Pepys

Showing results (1-10 of 82) with videos related to

Pageof 9
Sort By:
European Heart Journal|March 29, 2021
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?Mark B Pepys
Frontiers in Immunology|November 22, 2018
The Pentraxins 1975-2018: Serendipity, Diagnostics and DrugsMark B Pepys
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 2005
CRP or not CRP? That is the questionMark B Pepys
Journal of Internal Medicine|January 21, 2021
Transthyretin amyloidosis: new answers but many questionsMark B Pepys
The Journal of Allergy and Clinical Immunology|July 1, 2008
Jack Pepys (May 15, 1914-September 9, 1996): a personal recollectionMark B Pepys
The Journal of Pathology|December 9, 2008
A molecular correlate of clinicopathology in transthyretin amyloidosisMark B Pepys
The Journal of Infectious Diseases|August 29, 2012
Invasive candidiasis: new insights presaging new therapeutic approaches?Mark B Pepys
Annual Review of Medicine|January 18, 2006
AmyloidosisMark B Pepys
Nature Clinical Practice. Nephrology|March 5, 2008
C-reactive protein is neither a marker nor a mediator of atherosclerosisMark B Pepys
Clinical Medicine (London, England)|January 16, 2008
Science and serendipityMark B Pepys
Pageof 9

Showing results (1-10 of 82) with videos related to

Sort By:
Pageof 9
European Heart Journal|March 29, 2021
C-reactive protein predicts outcome in COVID-19: is it also a therapeutic target?Mark B Pepys
Frontiers in Immunology|November 22, 2018
The Pentraxins 1975-2018: Serendipity, Diagnostics and DrugsMark B Pepys
Arteriosclerosis, Thrombosis, and Vascular Biology|June 1, 2005
CRP or not CRP? That is the questionMark B Pepys
Journal of Internal Medicine|January 21, 2021
Transthyretin amyloidosis: new answers but many questionsMark B Pepys
The Journal of Allergy and Clinical Immunology|July 1, 2008
Jack Pepys (May 15, 1914-September 9, 1996): a personal recollectionMark B Pepys
The Journal of Pathology|December 9, 2008
A molecular correlate of clinicopathology in transthyretin amyloidosisMark B Pepys
The Journal of Infectious Diseases|August 29, 2012
Invasive candidiasis: new insights presaging new therapeutic approaches?Mark B Pepys
Annual Review of Medicine|January 18, 2006
AmyloidosisMark B Pepys
Nature Clinical Practice. Nephrology|March 5, 2008
C-reactive protein is neither a marker nor a mediator of atherosclerosisMark B Pepys
Clinical Medicine (London, England)|January 16, 2008
Science and serendipityMark B Pepys
Pageof 9